Eastgate Biotech Corp. (ETBI)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
At close: Mar 13, 2026
Eastgate Biotech Revenue
Eastgate Biotech had revenue of $23.14K in the quarter ending September 30, 2017. This brings the company's revenue in the last twelve months to $137.64K, up 45,325.08% year-over-year.
Revenue (ttm)
137.64K
Revenue Growth
+45,325.08%
P/S Ratio
7.69
Revenue / Employee
45.88K
Employees
3
Market Cap
1.06M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Iterum Therapeutics | 390.00K |
| International Stem Cell | 9.10M |
| Evofem Biosciences | 20.18M |
| LakeShore Biopharma | 84.75M |
| Lyra Therapeutics | 398.00K |
| Halberd | 6.94K |